Literature DB >> 25447765

Endothelial dysfunction impairs vascular neurotransmission in tail arteries.

Joana B Sousa1, Paula Fresco1, Carmen Diniz2.   

Abstract

The present study intends to clarify if endothelium dysfunction impairs vascular sympathetic neurotransmission. Electrically-evoked tritium overflow (100 pulses/5 Hz) was evaluated in arteries (intact and denuded) or exhibiting some degree of endothelium dysfunction (spontaneously hypertensive arteries), pre-incubated with [(3)H]-noradrenaline in the presence of enzymes (nitric oxide synthase (NOS); nicotinamide adenine dinucleotide phosphate (NADPH) oxidase; xanthine oxidase; cyclooxygenase; adenosine kinase) inhibitors and a nucleoside transporter inhibitor. Inhibition of endothelial nitric oxide synthase with L-NIO dihydrochloride reduced tritium overflow in intact arteries whereas inhibition of neuronal nitric oxide synthase with Nω-Propyl-L-arginine hydrochloride was devoid of effect showing that only endothelial nitric oxide synthase is involved in vascular sympathetic neuromodulation. Inhibition of enzymes involved in reactive oxygen species or prostaglandins production with apocynin and allopurinol or indomethacin, respectively, failed to alter tritium overflow. A facilitation or reduction of tritium overflow was observed in the presence of 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) or of 5-iodotubericidin, respectively, but only in intact arteries. These effects can be ascribed to a tonic inhibitory effect mediated by A1 receptors. In denuded and hypertensive arteries, 7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidine (SCH 58261) reduced tritium overflow, suggesting the occurrence of a tonic activation of A2A receptors. When endogenous adenosine bioavailability was increased by the nucleoside transporter inhibitor, S-(4-Nitrobenzyl)-6-thioinosine, tritium overflow increased in intact, denuded and hypertensive arteries. Among the endothelium-derived substances studied that could alter vascular sympathetic transmission only adenosine/adenosine receptor mediated mechanisms were clearly impaired by endothelium injury/dysfunction.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adenosine; Endothelium dysfunction; Nitric oxide; Noradrenaline; SHR

Mesh:

Substances:

Year:  2014        PMID: 25447765     DOI: 10.1016/j.neuint.2014.11.001

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  6 in total

1.  mTOR Attenuation with Rapamycin Reverses Neurovascular Uncoupling and Memory Deficits in Mice Modeling Alzheimer's Disease.

Authors:  Candice E Van Skike; Stacy A Hussong; Stephen F Hernandez; Andy Q Banh; Nicholas DeRosa; Veronica Galvan
Journal:  J Neurosci       Date:  2021-04-22       Impact factor: 6.167

2.  Vascular impairment of adenosinergic system in hypertension: increased adenosine bioavailability and differential distribution of adenosine receptors and nucleoside transporters.

Authors:  Ana Sousa-Oliveira; Ana Brandão; Martin Vojtek; Salomé Gonçalves-Monteiro; Joana B Sousa; Carmen Diniz
Journal:  Histochem Cell Biol       Date:  2018-10-24       Impact factor: 4.304

3.  Endothelial and Neuronal Nitric Oxide Activate Distinct Pathways on Sympathetic Neurotransmission in Rat Tail and Mesenteric Arteries.

Authors:  Joana Beatriz Sousa; Maria Sofia Vieira-Rocha; Silvia M Arribas; Maria Carmen González; Paula Fresco; Carmen Diniz
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

4.  Decompensated liver cirrhosis and neural regulation of mesenteric vascular tone in rats: role of sympathetic, nitrergic and sensory innervations.

Authors:  Esther Sastre; Laura Caracuel; Isabel Prieto; Pablo Llévenes; M Ángeles Aller; Jaime Arias; Gloria Balfagón; Javier Blanco-Rivero
Journal:  Sci Rep       Date:  2016-08-03       Impact factor: 4.379

Review 5.  The Adenosinergic System as a Therapeutic Target in the Vasculature: New Ligands and Challenges.

Authors:  Joana Beatriz Sousa; Carmen Diniz
Journal:  Molecules       Date:  2017-05-06       Impact factor: 4.411

Review 6.  Impact of Non-Pharmacological Interventions on the Mechanisms of Atherosclerosis.

Authors:  Daniela Matei; Ioana Buculei; Catalina Luca; Calin-Petru Corciova; Doru Andritoi; Robert Fuior; Daniel-Andrei Iordan; Ilie Onu
Journal:  Int J Mol Sci       Date:  2022-08-13       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.